Aktie WELCURE6 WELCURE DRUGS & PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Welcure Drugs & Pharmaceuticals Limited

Aktien

WELCURE6

INE331C01017

WELCURE6

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 09:00:42 18.05.2024 		% 5 Tage % 1. Jan.
5,4 INR 0,00 % Intraday Chart für Welcure Drugs & Pharmaceuticals Limited +12,50 % +40,26 %
22.03. Welcure Drugs & Pharmaceuticals Limited gibt den Rücktritt von Priti Rajesh Kharwar als zusätzliches Verwaltungsratsmitglied mit Wirkung vom 28. März 2024 bekannt CI
15.02. Welcure Drugs & Pharmaceuticals Limited gibt Rücktritte im Vorstand bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. WELCURE6 Aktie
  4. Nachrichten Welcure Drugs & Pharmaceuticals Limited
  5. Andere Sprachen